Cellestia Biotech
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+41 616332980Website
www.cellestia.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
About Cellestia Biotech
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cellestia Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cellestia Biotech has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cellestia Biotech recently announced quarterly report
Check out if Cellestia Biotech is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cellestia Biotech
Funding: Get notified immidiatlly once Cellestia Biotech has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cellestia Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cellestia Biotech had a recent Job posting/layoffs
Product Launch: Get notified when Cellestia Biotech launches new products
Recommended Actions
Reach out to Masked Content who joined Cellestia Biotech as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cellestia Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cellestia Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellestia Biotech.
Cellestia Biotech financials insights
Gather financial insights about Cellestia Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$5.2M
Series A
$21.3M
Series B
$20.4M
Cellestia Biotech Tech Stack
A closer look at the technologies used by Cellestia Biotech
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellestia Biotech
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-drug resistant cancers.... Read More
